ACAD logo

ACADIA Pharmaceuticals (ACAD) Non current assets

Annual non current assets:

$249.44M+$116.61M(+87.79%)
December 31, 2024

Summary

  • As of today (May 18, 2025), ACAD annual long term assets is $249.44 million, with the most recent change of +$116.61 million (+87.79%) on December 31, 2024.
  • During the last 3 years, ACAD annual non current assets has risen by +$167.14 million (+203.09%).
  • ACAD annual non current assets is now at all-time high.

Performance

ACAD Non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

quarterly non current assets:

$261.42M+$11.98M(+4.80%)
March 31, 2025

Summary

  • As of today (May 18, 2025), ACAD quarterly long term assets is $261.42 million, with the most recent change of +$11.98 million (+4.80%) on March 31, 2025.
  • Over the past year, ACAD quarterly non current assets has increased by +$81.61 million (+45.39%).
  • ACAD quarterly non current assets is now at all-time high.

Performance

ACAD quarterly non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

Non current assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

ACAD Non current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+87.8%+45.4%
3 y3 years+203.1%+218.7%
5 y5 years+987.7%+1035.2%

ACAD Non current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+212.3%at high+227.3%
5 y5-yearat high+987.7%at high+1035.2%
alltimeall timeat high>+9999.0%at high>+9999.0%

ACAD Non current assets History

DateAnnualQuarterly
Mar 2025
-
$261.42M(+4.8%)
Dec 2024
$938.32M(+52.3%)
$249.44M(+32.3%)
Sep 2024
-
$188.58M(+1.8%)
Jun 2024
-
$185.18M(+3.0%)
Mar 2024
-
$179.81M(+35.4%)
Dec 2023
$616.13M(+21.3%)
$132.83M(-0.4%)
Sep 2023
-
$133.37M(-11.2%)
Jun 2023
-
$150.14M(-1.5%)
Mar 2023
-
$152.46M(+90.9%)
Dec 2022
$507.94M(-17.8%)
$79.88M(-1.3%)
Sep 2022
-
$80.94M(+0.9%)
Jun 2022
-
$80.25M(-2.2%)
Mar 2022
-
$82.03M(-0.3%)
Dec 2021
$617.82M(-13.9%)
$82.30M(+7.2%)
Sep 2021
-
$76.76M(-2.5%)
Jun 2021
-
$78.70M(-3.1%)
Mar 2021
-
$81.19M(+24.9%)
Dec 2020
$717.62M(-5.6%)
$65.00M(-0.7%)
Sep 2020
-
$65.45M(+173.7%)
Jun 2020
-
$23.91M(+3.8%)
Mar 2020
-
$23.03M(+0.4%)
Dec 2019
$760.25M(+44.5%)
$22.93M(-1.4%)
Sep 2019
-
$23.26M(-2.9%)
Jun 2019
-
$23.94M(-3.1%)
Mar 2019
-
$24.70M(+75.2%)
Dec 2018
$526.11M(+40.9%)
$14.10M(+14.2%)
Sep 2018
-
$12.34M(-11.0%)
Jun 2018
-
$13.86M(+25.7%)
Mar 2018
-
$11.03M(-0.0%)
Dec 2017
$373.48M(-31.8%)
$11.03M(-6.1%)
Sep 2017
-
$11.74M(-6.6%)
Jun 2017
-
$12.57M(-5.2%)
Mar 2017
-
$13.26M(+0.0%)
Dec 2016
$547.90M(+150.2%)
$13.26M(-4.6%)
Sep 2016
-
$13.89M(-1.7%)
Jun 2016
-
$14.14M(+233.6%)
Mar 2016
-
$4.24M(+45.8%)
Dec 2015
$218.99M(-32.5%)
$2.91M(+17.5%)
Sep 2015
-
$2.47M(+15.2%)
Jun 2015
-
$2.15M(+4.0%)
Mar 2015
-
$2.06M(+145.7%)
Dec 2014
$324.62M
$840.00K(+20.3%)
Sep 2014
-
$698.00K(+14.2%)
DateAnnualQuarterly
Jun 2014
-
$611.00K(-10.9%)
Mar 2014
-
$686.00K(-9.5%)
Dec 2013
$188.36M(+73.5%)
$758.00K(+24.3%)
Sep 2013
-
$610.00K(+312.2%)
Jun 2013
-
$148.00K(+393.3%)
Mar 2013
-
$30.00K(-28.6%)
Dec 2012
$108.55M(+239.8%)
$42.00K(-35.4%)
Sep 2012
-
$65.00K(-34.3%)
Jun 2012
-
$99.00K(-25.0%)
Mar 2012
-
$132.00K(-20.0%)
Dec 2011
$31.95M(-15.6%)
$165.00K(-36.3%)
Sep 2011
-
$259.00K(-11.9%)
Jun 2011
-
$294.00K(-13.3%)
Mar 2011
-
$339.00K(-37.8%)
Dec 2010
$37.85M(-21.9%)
$545.00K(-28.1%)
Sep 2010
-
$758.00K(-10.6%)
Jun 2010
-
$848.00K(-15.7%)
Mar 2010
-
$1.01M(-16.7%)
Dec 2009
$48.47M(-22.3%)
$1.21M(-27.8%)
Sep 2009
-
$1.67M(-9.6%)
Jun 2009
-
$1.85M(-11.3%)
Mar 2009
-
$2.08M(-9.2%)
Dec 2008
$62.38M(-52.5%)
$2.29M(-14.0%)
Sep 2008
-
$2.67M(-10.3%)
Jun 2008
-
$2.97M(-5.8%)
Mar 2008
-
$3.15M(-5.3%)
Dec 2007
$131.25M(+53.0%)
$3.33M(-1.9%)
Sep 2007
-
$3.40M(+2.0%)
Jun 2007
-
$3.33M(-1.6%)
Mar 2007
-
$3.38M(-10.1%)
Dec 2006
$85.78M(+42.7%)
$3.76M(+20.9%)
Sep 2006
-
$3.11M(+7.0%)
Jun 2006
-
$2.91M(+21.3%)
Mar 2006
-
$2.40M(+0.7%)
Dec 2005
$60.13M(+59.0%)
$2.38M(+4.8%)
Sep 2005
-
$2.27M(+1.7%)
Jun 2005
-
$2.23M(-1.7%)
Mar 2005
-
$2.27M(-10.8%)
Dec 2004
$37.82M(+33.8%)
$2.55M(-10.4%)
Sep 2004
-
$2.84M(-6.6%)
Jun 2004
-
$3.05M(-18.3%)
Mar 2004
-
$3.73M(+8.9%)
Dec 2003
$28.27M(+113.4%)
$3.42M
Dec 2002
$13.25M
-

FAQ

  • What is ACADIA Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual non current assets year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly non current assets year-on-year change?

What is ACADIA Pharmaceuticals annual long term assets?

The current annual non current assets of ACAD is $249.44M

What is the all time high annual non current assets for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual long term assets is $249.44M

What is ACADIA Pharmaceuticals annual non current assets year-on-year change?

Over the past year, ACAD annual long term assets has changed by +$116.61M (+87.79%)

What is ACADIA Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of ACAD is $261.42M

What is the all time high quarterly non current assets for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly long term assets is $261.42M

What is ACADIA Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, ACAD quarterly long term assets has changed by +$81.61M (+45.39%)
On this page